Mersana Therapeutics Inc (MRSN)
2.85
-0.03
(-1.04%)
USD |
NASDAQ |
Apr 25, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Market Cap: 345.71M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 345.71M |
| April 24, 2024 | 349.35M |
| April 23, 2024 | 389.38M |
| April 22, 2024 | 382.10M |
| April 19, 2024 | 394.23M |
| April 18, 2024 | 405.15M |
| April 17, 2024 | 426.99M |
| April 16, 2024 | 456.10M |
| April 15, 2024 | 459.74M |
| April 12, 2024 | 462.16M |
| April 11, 2024 | 451.25M |
| April 10, 2024 | 449.43M |
| April 09, 2024 | 497.34M |
| April 08, 2024 | 504.62M |
| April 05, 2024 | 519.18M |
| April 04, 2024 | 515.54M |
| April 03, 2024 | 539.80M |
| April 02, 2024 | 511.90M |
| April 01, 2024 | 536.16M |
| March 28, 2024 | 543.44M |
| March 27, 2024 | 544.65M |
| March 26, 2024 | 521.60M |
| March 25, 2024 | 517.96M |
| March 22, 2024 | 570.12M |
| March 21, 2024 | 583.47M |
| Date | Value |
|---|---|
| March 20, 2024 | 587.11M |
| March 19, 2024 | 601.66M |
| March 18, 2024 | 589.53M |
| March 15, 2024 | 611.37M |
| March 14, 2024 | 607.12M |
| March 13, 2024 | 696.28M |
| March 12, 2024 | 684.15M |
| March 11, 2024 | 690.21M |
| March 08, 2024 | 701.13M |
| March 07, 2024 | 709.62M |
| March 06, 2024 | 696.28M |
| March 05, 2024 | 699.92M |
| March 04, 2024 | 697.49M |
| March 01, 2024 | 720.54M |
| February 29, 2024 | 659.89M |
| February 28, 2024 | 588.32M |
| February 27, 2024 | 517.96M |
| February 26, 2024 | 492.49M |
| February 23, 2024 | 459.74M |
| February 22, 2024 | 456.29M |
| February 21, 2024 | 445.43M |
| February 20, 2024 | 438.18M |
| February 16, 2024 | 458.70M |
| February 15, 2024 | 463.53M |
| February 14, 2024 | 457.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
69.43M
Minimum
Oct 07 2019
1.890B
Maximum
Dec 23 2020
631.20M
Average
504.62M
Median
Apr 08 2024
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.004B |
| Geron Corp | 1.944B |
| TG Therapeutics Inc | 2.148B |
| Editas Medicine Inc | 427.07M |
| G1 Therapeutics Inc | 201.49M |
Market Cap Related Metrics
| PS Ratio | 8.976 |
| Price to Book Value | 9.368 |
| Price | 2.85 |
| Earnings Yield | -52.63% |